The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Rituximab

Back to Details
This is a "connection" page, showing publications Kenneth S. Cohen has written about Rituximab.
Kenneth S. Cohen
Connection Strength
0.157
Rituximab
  1. Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.